$100

Peptides
HMG
Human Menopausal Gonadotropin. Supplied as a lyophilised powder in 75 IU vials.
Supplied as lyophilised powder in a 75 IU specification. Storage: -20°C · Keep dry, avoid light. Dispatched from Sydney, Australia-wide.
Product information
About HMG
Human Menopausal Gonadotropin (Menotropins)
Research background as published in the scientific literature. Supplied for in-vitro laboratory research only; nothing here is a claim about use in humans or animals.
Human Menopausal Gonadotropin (HMG), also known as menotropins, is a preparation of gonadotropins with both follicle-stimulating hormone (FSH) and luteinising hormone (LH) activity. It is traditionally purified from the urine of postmenopausal women, in whom circulating gonadotropin levels are high.
Its potency is expressed in international units of biological activity rather than by weight: a 75 IU preparation is standardised to 75 IU of FSH activity and 75 IU of LH activity. In some preparations part of the LH activity is contributed by human chorionic gonadotropin.
HMG has been studied for decades in reproductive endocrinology. It is supplied here as a reference material for in-vitro laboratory research.
- Type
- Gonadotropin preparation — FSH and LH activity
- Research Areas
- FSH and LH receptor signalling, reproductive endocrinology
- Also Known As
- Menotropins
- Activity
- FSH and LH, 1:1
- CAS Number
- 9002-68-0
- Primary Receptors
- FSH receptor, LH/CG receptor
- Key Pathway
- cAMP/PKA — steroidogenesis
- 01FSH Receptor ActivationThe follicle-stimulating hormone activity in HMG acts at the FSH receptor. Research examines its effects on granulosa cells in ovarian models and on Sertoli cells in testicular models.
- 02LH Receptor ActivationThe luteinising hormone activity acts at the LH/CG receptor, the same receptor studied with HCG. Research examines steroidogenesis in theca and Leydig cell models through the cAMP/PKA pathway.
- 03Combined Gonadotropin ActivityBecause it carries both activities, HMG is used in reproductive endocrinology research to study how FSH and LH signalling act together on follicle development and steroid synthesis.
References
- 1Lunenfeld B. Historical perspectives in gonadotrophin therapy. Hum Reprod Update. 2004;10(6):453–467.
- 2DrugBank: Menotropins (DB00032).
- 3PubMed: pubmed.ncbi.nlm.nih.gov/?term=human+menopausal+gonadotropin
Also in this range.
Compounds the supplier files alongside this one.


